Effects of prostaglandin I2 and a selective thromboxane synthetase inhibitor on the arteriolar constriction caused by norepinephrine.
Effects of prostaglandin (PG) I2 and thromboxane (Tx) A2 on the systemic blood pressure, the internal diameter of arterioles with a diameter of 20 to 30 microns, and the change caused by the topical administration of norepinephrine (NE) were studied in the rat mesentery. The change in diameter was measured by an image-shearing eyepiece and television microscopy. The rats were divided into three groups. Group I (9 rats) served as the non-treated, control group. In group II (6 rats), PGI2 was given at the rate of 0.6 micrograms/kg/min for ten minutes. In group III (6 rats), (E)-3-[4-(1-imidazolylmethyl)phenyl]-2-propenoic acid hydrochloride monohydrate (OKY 046), which is a highly selective TxA2 synthetase inhibitor, was administered at the rate of 0.5 mg/kg/min for ten minutes. The hypotension caused by PGI2 administration was accompanied by arteriolar constriction, although it disappeared with the increase in the systemic blood pressure five minutes after administration of PGI2 was stopped. The systemic blood pressure and the internal diameter of arterioles showed no change in the OKY 046 and in the control group. The vasoconstrictive response to NE was inhibited by PGI2 and OKY 046 for thirty to forty-five minutes and the inhibitory effects were similar in both cases. These results show that PGI2 and a selective Tx synthetase inhibitor, OKY 046, attenuate the vascular response to NE.
Kato
T
T
Department of Anesthesiology, Toyokawa City Hospital, Japan.
Goto
Y
Y
Yoneda
S
S
Yamamoto
K
K
Aochi
O
O
D000179:Acrylates / Q000494:pharmacology*; D000287:Administration, Topical; D000818:Animals; D001158:Arteries / Q000187:drug effects*; D001160:Arterioles / Q000187:drug effects* / Q000502:physiology; D001794:Blood Pressure / Q000187:drug effects; D011464:Epoprostenol / Q000494:pharmacology*; D008297:Male; D008689:Methacrylates / Q000494:pharmacology*; D008833:Microcirculation / Q000187:drug effects; D009638:Norepinephrine / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D014661:Vasoconstriction / Q000187:drug effects*
D000179:Acrylates; D008689:Methacrylates; D011464:Epoprostenol; C034364:ozagrel; D009638:Norepinephrine